D-0395-2024 Class II Terminated

Recalled by SCA Pharmaceuticals, LLC — Windsor, CT

FDA drug recall D-0395-2024 was initiated by SCA Pharmaceuticals, LLC on Nov 9, 2023 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Aug 27, 2024). Affected quantity: 548 bags.

Recall details

Product Type
Drugs
Report Date
Apr 3, 2024
Initiation Date
Nov 9, 2023
Termination Date
Aug 27, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
548 bags

Product description

fentaNYL 2,500 mcg/250 mL in 0.9% Sodium Chloride Injection (Concentration = 10 mcg/mL), 250 mL Bag, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, 877.550.5059, NDC 70004-0229-40 BAR code 70004022940

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide in the USA

Code information

Lot #: 1223045757, Exp 12/27/23; 1223049716, Exp 5/25/24

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0395-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0395-2024. Report a data issue: hello@regdatalab.com.